Home for the Holiday: Last-gasp Drug Saves Seattle Baby’s Life

Home for the Holiday: Last-gasp Drug Saves Seattle Baby’s Life

Source: The Seattle Times

A Seattle baby is home in time for Christmas after local doctors bet on a last-chance, once-discarded treatment that uses liquid, not air, to inflate the collapsed lungs of fragile newborns. Tatiana Saiaana, now nearly 4 months old, smiled and stared with big brown eyes at a sparkling tree in her family’s Seward Park-area home this week, safe in the lap of her mother, Elise Pele, 28. “She’s doing great,” Pele said, cuddling the sturdy girl in the leopard-print sleeper. Just weeks ago, Tatiana was one of the most critically ill babies doctors at Seattle Children’s had ever seen. Before her birth via emergency cesarean section on Aug. 29, Tatiana had inhaled meconium, a mixture of fetal stool and amniotic fluid, causing severe respiratory distress.

About Seattle Children’s

Consistently ranked as one of the best children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical referral center for the largest landmass of any children’s hospital in the country (Washington, Alaska, Montana and Idaho). For more than 100 years, Seattle Children’s has been delivering superior patient care while advancing new treatments through pediatric research. Seattle Children’s serves as the primary teaching, clinical and research site for the Department of Pediatrics at the University of Washington School of Medicine. The hospital works in partnership with Seattle Children’s Research Institute and Seattle Children’s Hospital Foundation. For more information, visit or follow us on Twitter or Facebook.